Cargando…

In vitro safety assessment of electrohydrodynamically encapsulated Lactiplantibacillus plantarum CRD7 and Lacticaseibacillus rhamnosus CRD11 for probiotics use

The current study aimed to validate the safety of electrohydrodynamically encapsulated Lactiplantibacillus plantarum CRD7 and Lacticaseibacillus rhamnosus CRD11 in accordance with guidelines of FAO/WHO and ICMR/DBT. In vitro assays such as mucin degradation, hemolysis of blood cells, antimicrobial s...

Descripción completa

Detalles Bibliográficos
Autores principales: Varada, Vinay Venkatesh, Panneerselvam, Divya, Pushpadass, Heartwin A., Mallapa, Rashmi Hogarehalli, Ram, Chand, Kumar, Sachin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196993/
https://www.ncbi.nlm.nih.gov/pubmed/37215740
http://dx.doi.org/10.1016/j.crfs.2023.100507
_version_ 1785044458425810944
author Varada, Vinay Venkatesh
Panneerselvam, Divya
Pushpadass, Heartwin A.
Mallapa, Rashmi Hogarehalli
Ram, Chand
Kumar, Sachin
author_facet Varada, Vinay Venkatesh
Panneerselvam, Divya
Pushpadass, Heartwin A.
Mallapa, Rashmi Hogarehalli
Ram, Chand
Kumar, Sachin
author_sort Varada, Vinay Venkatesh
collection PubMed
description The current study aimed to validate the safety of electrohydrodynamically encapsulated Lactiplantibacillus plantarum CRD7 and Lacticaseibacillus rhamnosus CRD11 in accordance with guidelines of FAO/WHO and ICMR/DBT. In vitro assays such as mucin degradation, hemolysis of blood cells, antimicrobial susceptibility pattern, possession of virulence factors, biogenic amine, and ammonia production were assessed. In results, the cross-streak and co-culture techniques revealed that CRD7 and CRD11 were compatible in vitro. Upon visual inspection through scanning electron and fluorescence microscopy, the integrity of bacterial cell membrane was confirmed even after the encapsulation process. CRD7 and CRD11 were non-hemolytic and showed negative responses to gelatinase, urease, and DNase activities. Non-mucinolytic activity of CRD7 and CRD11 was verified by measuring cell growth rate (p < 0.05) in different modified media followed by SDS-PAGE. High-performance liquid chromatography analysis revealed that both the strains did not produce biogenic amines (putrescine, cadaverine, histamine, and tyramine). Neither of the Lactobacillus strains produced ammonia after growing in BHI broth for 5 days at 37 °C. L-lactate production was highest (p < 0.05) in CRD11 (8.83 g/L), followed by CRD7 (8.16 g/L), whereas the lowest (p < 0.05) D-lactate was registered for encapsulated CRD11 (0.33 g/L) and CRD7 (0.49 g/L). The antibiogram profile determined through minimum inhibitory concentration showed that CRD7 and CRD11 were sensitive to key antibiotics suggested by EFSA except for gentamycin and kanamycin. PCR data on virulence genes demonstrated that both strains were safe for probiotic use. Moreover, CRD7 and CRD11 strains caused insignificant (p > 0.05) changes in the cell viability of Caco-2 cells as estimated by MTT (98.94–99.50%) and NR uptake (95.42–97.03%) assays and showed sensitivity to human serum. According to the results of these evaluated attributes, it is concluded that L. plantarum CRD7 and L. rhamnosus CRD11 are safe, non-toxic to human epithelial cells, and thus may be potentially suitable for various food/feed applications.
format Online
Article
Text
id pubmed-10196993
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-101969932023-05-20 In vitro safety assessment of electrohydrodynamically encapsulated Lactiplantibacillus plantarum CRD7 and Lacticaseibacillus rhamnosus CRD11 for probiotics use Varada, Vinay Venkatesh Panneerselvam, Divya Pushpadass, Heartwin A. Mallapa, Rashmi Hogarehalli Ram, Chand Kumar, Sachin Curr Res Food Sci Research Article The current study aimed to validate the safety of electrohydrodynamically encapsulated Lactiplantibacillus plantarum CRD7 and Lacticaseibacillus rhamnosus CRD11 in accordance with guidelines of FAO/WHO and ICMR/DBT. In vitro assays such as mucin degradation, hemolysis of blood cells, antimicrobial susceptibility pattern, possession of virulence factors, biogenic amine, and ammonia production were assessed. In results, the cross-streak and co-culture techniques revealed that CRD7 and CRD11 were compatible in vitro. Upon visual inspection through scanning electron and fluorescence microscopy, the integrity of bacterial cell membrane was confirmed even after the encapsulation process. CRD7 and CRD11 were non-hemolytic and showed negative responses to gelatinase, urease, and DNase activities. Non-mucinolytic activity of CRD7 and CRD11 was verified by measuring cell growth rate (p < 0.05) in different modified media followed by SDS-PAGE. High-performance liquid chromatography analysis revealed that both the strains did not produce biogenic amines (putrescine, cadaverine, histamine, and tyramine). Neither of the Lactobacillus strains produced ammonia after growing in BHI broth for 5 days at 37 °C. L-lactate production was highest (p < 0.05) in CRD11 (8.83 g/L), followed by CRD7 (8.16 g/L), whereas the lowest (p < 0.05) D-lactate was registered for encapsulated CRD11 (0.33 g/L) and CRD7 (0.49 g/L). The antibiogram profile determined through minimum inhibitory concentration showed that CRD7 and CRD11 were sensitive to key antibiotics suggested by EFSA except for gentamycin and kanamycin. PCR data on virulence genes demonstrated that both strains were safe for probiotic use. Moreover, CRD7 and CRD11 strains caused insignificant (p > 0.05) changes in the cell viability of Caco-2 cells as estimated by MTT (98.94–99.50%) and NR uptake (95.42–97.03%) assays and showed sensitivity to human serum. According to the results of these evaluated attributes, it is concluded that L. plantarum CRD7 and L. rhamnosus CRD11 are safe, non-toxic to human epithelial cells, and thus may be potentially suitable for various food/feed applications. Elsevier 2023-04-22 /pmc/articles/PMC10196993/ /pubmed/37215740 http://dx.doi.org/10.1016/j.crfs.2023.100507 Text en © 2023 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research Article
Varada, Vinay Venkatesh
Panneerselvam, Divya
Pushpadass, Heartwin A.
Mallapa, Rashmi Hogarehalli
Ram, Chand
Kumar, Sachin
In vitro safety assessment of electrohydrodynamically encapsulated Lactiplantibacillus plantarum CRD7 and Lacticaseibacillus rhamnosus CRD11 for probiotics use
title In vitro safety assessment of electrohydrodynamically encapsulated Lactiplantibacillus plantarum CRD7 and Lacticaseibacillus rhamnosus CRD11 for probiotics use
title_full In vitro safety assessment of electrohydrodynamically encapsulated Lactiplantibacillus plantarum CRD7 and Lacticaseibacillus rhamnosus CRD11 for probiotics use
title_fullStr In vitro safety assessment of electrohydrodynamically encapsulated Lactiplantibacillus plantarum CRD7 and Lacticaseibacillus rhamnosus CRD11 for probiotics use
title_full_unstemmed In vitro safety assessment of electrohydrodynamically encapsulated Lactiplantibacillus plantarum CRD7 and Lacticaseibacillus rhamnosus CRD11 for probiotics use
title_short In vitro safety assessment of electrohydrodynamically encapsulated Lactiplantibacillus plantarum CRD7 and Lacticaseibacillus rhamnosus CRD11 for probiotics use
title_sort in vitro safety assessment of electrohydrodynamically encapsulated lactiplantibacillus plantarum crd7 and lacticaseibacillus rhamnosus crd11 for probiotics use
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196993/
https://www.ncbi.nlm.nih.gov/pubmed/37215740
http://dx.doi.org/10.1016/j.crfs.2023.100507
work_keys_str_mv AT varadavinayvenkatesh invitrosafetyassessmentofelectrohydrodynamicallyencapsulatedlactiplantibacillusplantarumcrd7andlacticaseibacillusrhamnosuscrd11forprobioticsuse
AT panneerselvamdivya invitrosafetyassessmentofelectrohydrodynamicallyencapsulatedlactiplantibacillusplantarumcrd7andlacticaseibacillusrhamnosuscrd11forprobioticsuse
AT pushpadassheartwina invitrosafetyassessmentofelectrohydrodynamicallyencapsulatedlactiplantibacillusplantarumcrd7andlacticaseibacillusrhamnosuscrd11forprobioticsuse
AT mallaparashmihogarehalli invitrosafetyassessmentofelectrohydrodynamicallyencapsulatedlactiplantibacillusplantarumcrd7andlacticaseibacillusrhamnosuscrd11forprobioticsuse
AT ramchand invitrosafetyassessmentofelectrohydrodynamicallyencapsulatedlactiplantibacillusplantarumcrd7andlacticaseibacillusrhamnosuscrd11forprobioticsuse
AT kumarsachin invitrosafetyassessmentofelectrohydrodynamicallyencapsulatedlactiplantibacillusplantarumcrd7andlacticaseibacillusrhamnosuscrd11forprobioticsuse